References
- WenPYKesariSMalignant gliomas in adultsN Engl J Med200835949250718669428
- StummerWPichlmeierUMeinelTWiestlerODZanellaFReulenHJFluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialLancet Oncol2006739240116648043
- LaperriereNZurawLCairncrossGRadiotherapy for newly diagnosed malignant glioma in adults: a systematic reviewRadiother Oncol20026425927312242114
- WalkerMDGreenSBByarDPRandomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgeryN Engl J Med1980303132313297001230
- TrivediRNAlmeidaKHFornsaglioJLSchamusSSobolRWThe role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell deathCancer Res2005656394640016024643
- TentoriLGrazianiGPharmacological strategies to increase the anti-tumor activity of methylating agentsCurr Med Chem200291285130112052167
- StevensMENewlandsESFrom triazines and triazenes to temozolomideEur J Cancer199329A104510478499135
- StuppRHegiMEMasonWPEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet200910459466
- WickWEngelCCombsSENOA-08 randomized phase III trial of 1-week-on/1-week-off temozolomide versus involved-field radiotherapy in elderly (older than age 65) patients with newly diagnosed anaplastic astrocytoma or glioblastoma (Methusalem)J Clin Oncol201028SupplLBA2001
- D’AgostinoGBalducciMAnileCAn analysis of two different schedules of radiochemotherapy with concomitant temozolomide in high grade gliomasJ Clin Oncol200725Suppl203517513807
- TherassePArbuckSGEisenhauerEANew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst20009220521610655437
- KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc195853457481
- MantelNEvaluation of survival data and two new rank order statistics arising in its considerationCancer Chemother Rep1966501631705910392
- CoxDRRegression models and life tablesJ R Stat Soc Series B Stat Methodol197234187220
- Cancer Therapy Evaluation ProgramCommon terminology criteria for adverse events v3.0 (CTCAE)2006 Available from: http://www.eortc.be/services/doc/ctc/ctcaev3.pdfAccessed February 28, 2013
- NewlandsESStevensMFWedgeSRWheelhouseRTBrockCTemozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trialsCancer Treat Rev19972335619189180
- BrockCSNewlandsESWedgeSRPhase I trial of temozolomide using an extended continuous oral scheduleCancer Res199858436343679766665
- StuppRDietrichPYOstermann KraljevicSPromising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomideJ Clin Oncol2002201375138211870182